Timothy Coughlin insider trades

Open-market stock purchases and sales by Timothy Coughlin, Unknown at Travere Therapeutics, Inc, from SEC Form 4 filings since Oct 31, 2025.

Recent trades

DateStockTradeValue
Jun 12, 2026TVTX Travere Therapeutics, IncSold$501K
Jun 12, 2026TVTX Travere Therapeutics, IncBought (not open market)—
Jun 9, 2026VIR Vir Biotechnology, IncBought (not open market)—
Jun 9, 2026VIR Vir Biotechnology, IncBought (not open market)—
Jun 3, 2026ADCT ADC Therapeutics SASold (not open market)$38.8K
Jun 1, 2026ADCT ADC Therapeutics SABought (not open market)—
May 19, 2026TVTX Travere Therapeutics, IncBought (not open market)—
May 19, 2026TVTX Travere Therapeutics, IncBought (not open market)—
May 15, 2026TVTX Travere Therapeutics, IncSold$141K
May 11, 2026ATYR aTYR PHARMA IncBought (not open market)—
Oct 31, 2025TVTX Travere Therapeutics, IncBought (not open market)—
Oct 31, 2025TVTX Travere Therapeutics, IncSold$631K
Oct 31, 2025TVTX Travere Therapeutics, IncBought (not open market)—

Companies traded

  • TVTX Travere Therapeutics, Inc: 3 sales, last Jun 12, 2026
  • VIR Vir Biotechnology, Inc: other filings, last Jun 9, 2026
  • ADCT ADC Therapeutics SA: other filings, last Jun 3, 2026
  • ATYR aTYR PHARMA Inc: other filings, last May 11, 2026

Get free alerts when Timothy Coughlin files a new trade →